These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17362590)

  • 41. Why, when and how to initiate insulin therapy in patients with type 2 diabetes.
    Tibaldi J; Rakel RE
    Int J Clin Pract; 2007 Apr; 61(4):633-44. PubMed ID: 17394436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Refining basal insulin therapy: what have we learned in the age of analogues?
    Devries JH; Nattrass M; Pieber TR
    Diabetes Metab Res Rev; 2007 Sep; 23(6):441-54. PubMed ID: 17668418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diluent Multiassay for the MODULAR ANALYTICS E170 does not improve TSH dilutions compared to Diluent Universal.
    Rigo RF; Alía P; Rosel P; Navarro MA
    Clin Chem Lab Med; 2006; 44(3):353-4. PubMed ID: 16519611
    [No Abstract]   [Full Text] [Related]  

  • 44. Was insulin review biased, or simply a victim of bad timing?
    Brunton S
    J Fam Pract; 2007 May; 56(5):E1-4; author reply E1-4. PubMed ID: 17475156
    [No Abstract]   [Full Text] [Related]  

  • 45. Was insulin review biased, or simply a victim of bad timing?
    Heise T
    J Fam Pract; 2007 May; 56(5):E1-4; author reply E1-4. PubMed ID: 17611994
    [No Abstract]   [Full Text] [Related]  

  • 46. New insulin analogues and insulin delivery devices for the perioperative management of diabetic patients.
    Ferrari LR
    Curr Opin Anaesthesiol; 2008 Jun; 21(3):401-5. PubMed ID: 18458562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report.
    Yumlu S; Barany R; Eriksson M; Röcken C
    Hum Pathol; 2009 Nov; 40(11):1655-60. PubMed ID: 19683329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Particle-based tests and assays--pitfalls and problems in preparation.
    Bangs LB
    Am Clin Lab; 1990 May; 9(4):16-7. PubMed ID: 10148248
    [No Abstract]   [Full Text] [Related]  

  • 49. Performance Evaluation of Mindray SAL 8000: a New Integrated Clinical Chemistry and Immunoassay Analyzer System.
    Yang J; Li M; Zhang H; Zhang P; Zhao L; Zeng D; Li L; Fan H; Zeng F
    Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conventional therapy with insulin.
    Nattrass M
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):13-6. PubMed ID: 19667600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prescription of insulin glargine in primary care practices in Germany.
    Rathmann W; Haastert B; Riebel P; Schroeder-Bernhardi D; Kostev K; Huppertz E; Giani G
    Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):252-6. PubMed ID: 17479442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2008 resource guide. Insulin. Along with human insulin analogs, recombinant DNA human insulins are the most widely used insulins in this country. Through genetic engineering, bacteria or yeast are transformed into little "factories" that produce synthetic human insulin.
    Diabetes Forecast; 2008 Jan; 61(1):RG11-4. PubMed ID: 18290288
    [No Abstract]   [Full Text] [Related]  

  • 54. Biphasic insulin aspart 30 treatment improves glycemic control among patients with type 2 diabetes in Saudi Arabia and the Gulf region.
    Ayad NM; Fattah WA; Bakry H
    Saudi Med J; 2008 Jun; 29(6):919-20. PubMed ID: 18521482
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.
    Luzio S; Peter R; Dunseath GJ; Mustafa L; Owens DR
    Diabetes Res Clin Pract; 2008 Feb; 79(2):269-75. PubMed ID: 18164094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of glargine in pregnancy.
    Tahrani AA; Varughese GI
    BJOG; 2007 Sep; 114(9):1178-9; author reply 1179-80. PubMed ID: 17803506
    [No Abstract]   [Full Text] [Related]  

  • 57. Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient.
    Meneghini L
    Int J Clin Pract; 2008 Aug; 62(8):1255-64. PubMed ID: 18705822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intensive insulin therapy and insulin pumps.
    Bode BW
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin analogs and pregnancy: an update.
    Torlone E; Di Cianni G; Mannino D; Lapolla A
    Acta Diabetol; 2009 Sep; 46(3):163-72. PubMed ID: 19572099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin glargine (Lantus) and cancer risk.
    Med Lett Drugs Ther; 2009 Aug; 51(1319):67-8. PubMed ID: 19696708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.